SpaceX OpenAI and Anthropic IPOs Could Trigger Major Wall Street Rebalancing PRGO Q1 2026 Earnings Strong EPS Beat Drives Positive Market Reaction JOE Q1 2026 Earnings EPS of 024 Meets Expectations Stock Declines Slightly Marker Therapeutics Q1 2026 Earnings Loss Narrows as Clinical Progress Continues HERE Q4 2025 Earnings EPS Surges Over 1150 Above Estimates Yet Shares Dip